Cargando…
541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
BACKGROUND: Since the global outbreak of SARS-CoV-2, antiviral drugs have played a major role in the treatment of COVID-19 by reducing complications and mortality. Remdesivir is an effective therapeutic option for hospitalized patients with risk for clinical progression with COVID-19 who cannot rece...
Autores principales: | Platzer, Moritz, Totschnig, David, Wenisch, Christoph, Zoufaly, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677172/ http://dx.doi.org/10.1093/ofid/ofad500.610 |
Ejemplares similares
-
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022) -
A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
por: Groza, Cristina, et al.
Publicado: (2023) -
Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023) -
115. Evaluation of the Clinical Impact of the T2MR for the Diagnosis of Bloodstream Infections
por: Seitz, Tamara, et al.
Publicado: (2019) -
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients—A Single-Center Experience
por: Totschnig, David, et al.
Publicado: (2022)